By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Indian therapeutics and drug development services firm Advinus Therapeutics will collaborate with Corning to offer Corning's Epic label-free detection services in India.

Under the agreement, Pune-based Advinus will use the Epic technology in its drug discovery capabilities and to provide assay development and screening services in India and abroad. Financial and other terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.